Expansion opportunity Althea has recent and historical facility expansions in San Diego, indicating ongoing capacity growth and potential need for additional manufacturing capacity, process development, or cleanroom space to support client programs and scale-out projects.

Aseptic fill finish As a leading expert in aseptic fill finish for vials and syringes, there is a clear cross-sell opportunity to clients seeking robust fill finish capabilities, including high-potency and sterile manufacturing, for early-stage to commercial products.

Integrated CDMO Full end-to-end CDMO capabilities in a single location from process development to commercial manufacturing position Althea as a convenient partner for startups and mid-sized biotechs, enabling streamlined program timelines and potential bundling of services.

Financial health With revenue in the mid hundreds of millions and a significant growth-oriented funding profile, Althea is financially positioned to invest in capacity expansion, new capabilities, and long-term collaborations with biotech sponsors seeking reliability and scale.

Market alignment Industry demand for compliant, GMP-compliant manufacturing and early-stage-to-commercial support aligns with Althea’s capabilities, suggesting targeting of biotechs pursuing rapid scale-up, potent/HPPE projects, or global distribution, to capture share in a growing CDMO market.